Синкопальные состояния у детей с гипертрофической кардиомиопатией
https://doi.org/10.21508/1027-4065-2014-59-6-35-49
Аннотация
Об авторах
И. В. Леонтьева
Научно-исследовательский клинический институт педиатрии, Москва
Россия
Россия
д.м.н., проф., рук. отделения патологии сердечно-сосудистой системы НИКИ педиатрии
В. А. Макарова
Научно-исследовательский клинический институт педиатрии, Москва
Россия
асп. того же отдела
Россия
асп. того же отдела
С. А. Термосесов
Научно-исследовательский клинический институт педиатрии, Москва
Россия
Россия
зав. отделением хирургического лечения сложных нарушений сердечного ритма указанного учреждения 125412 Москва, ул. Талдомская, д. 2
Список литературы
1. Elliott P.M., Anastasakis A., Borger M.A. et al. 2014 ESC Guidelines on diagnosis and management of hypertropliic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology. Eur Heart J 2014; doi:10.1093/eurheartj/ehu284. www escardio.org/ guidelines.
2. Gersh B.J., Maron B.J., Bonow R.O. et al. ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American college of cardiology foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: 213—260.
3. Efthimiadis G., Pagourelias E., Gossios Т., Zegkos T. Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives. World J Cardiol 2014; 6: 2: 26—37.
4. Biagini E., Coccolo F., Ferlito M. et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 2005; 46: 1543—1550.
5. Maron В., Spirito P., Ackerman M. Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrfflators in Children and Adolescents With Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2013; 61: 14: 1527—1535.
6. Ostman-Smith I. Hypertrophic cardiomyopathy in childhood and adolescence — strategies to prevent sudden death. Fundam Clin Pharmacol 2010; 24: 637—652.
7. Ostman-Smith I., Wettrell G., Keeton B. et al. Age-and gender specific mortality rates in childhood hypertrophic cardiomyopathy. Eur Heart J 2008; 29: 1160—1167.
8. Maron B.J. Risk Stratification and Role of Implantable Deibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy. Circ J 2010; 74: 2271—2282.
9. Deccker J., Rossano J., Smith O. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children Am Coll Cardiol 2009; 54: 3: 250—254.
10. Anastasakis A., Theopistou A., Rigopoulos A., Kotsiopoulou С Sudden Cardiac Death: Investigation of the Classical Risk Factors in a Community-Based Hypertrophic Cardiomyopathy Cohort. Hellenic J Cardiol 2013; 54: 281—288.
11. Elliott P.M., Gimeno J.R., Tome M.T. et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 2006; 27: 1933-1941.
12. MoyaA., Sutton R, Ammirati F. et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J 2009; 30: 2631-2671.
13. Olivotto I., Cecchi F., Casey S.A. et al. Impact of atrial fibrillationon the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104: 2517—2524.
14. Bookstall K., Link M. A primer on arrhythmias in patients with hypertrophic Cardiomyopathy. Curr Cardiol Rep 2012; 14: 552-562.
15. Barriales-VillaR., Centurion-IndaR., Fernandez-FernandezX. et al. Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 2010; 63: 985-988.
16. Bahl A., Saikia U., Talwar K. Familial conduction system disease associated with hypertrophic cardiomyopathy. Int J Cardiol 2008; 125: 44-47.
17. Prasad K., Williams L., Campbell R. et al. Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation. Heart 2008; 94: 1312—1317.
18. Dimitrow P.P., Chojnowska L., Rudzinski T.S. et al. Sudden death in hypertrophic cardiomyopathy: old risk factors reassessed in a new model of maximalized follow-up. Eur Heart J 2010; 31: 3084-3093.
19. Efthimiadis G.K., Parcharidou D.G., Giannakoulas G. et al. Left ventricular out flow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 2009; 104: 695-699.
20. Gimeno J.R., Tome-Esteban M., Lofiego C. et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur Heart J 2009; 30: 2599-2605.
21. Pettersen M.D., Wei D., Skeens M.E., Humes R.A. Regression equations for calculation of Z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: An echocardiographic study. J Am Soc Echocardiogr 2008; 21: 8: 922-934.
22. BaurA., MalikM., Schmidt G. Heart rate turbulence: standards of measurement, physiological interpretation and clinical use. Amer Coll Cardiol 2008; 52: 17: 1353-1365.
23. Макарова В.А., Леонтьева И.В. Турбулентность ритма сердца как маркер электрической нестабильности миокарда. Рос вестн перинатол и педиат 2014; 4: 64—68. (Makarova V.A., Leontyeva I.V. Heart rate turbulence as a marker of myocardial electrical instability in children with hypertrophic cardiomyopathy. Ros vest perinatol i pediat 2014; 4: 65—68.)
24. Shah J.S., Esteban M.T., Thaman R. et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart 2008; 94: 1288—1294.
25. Monserrat L., Elliott P., Gimeno J. Non-Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy: An Independent Marker of Sudden Death Risk in Young Patients J Am Coll Cardiol 2003; 42: 5: 873-878.
26. Gilligan DM., Nihoyannopoulos P., Chan W.L., Oakley CM. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test. Circulation 1992; 85: 2140-2148.
27. Kawasaki Т., Sakai C, Harimoto K. Holter monitoring and long-term prognosis in hypertrophic Cardiomyopathy. Cardiology 2012; 122:44-54.
28. American Heart Association/American College of Cardiology Foundation/. Heart rhythm society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. Circulation 2008; 118: 1497-1518.
29. Shiozak A, Senra Т., Arteaga E. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients withhypertrophic cardiomyopathy JCardiovasc ComputTomogr2013; 7: 3: 173—181.
30. Schmidt G., Malik M., Barthel P. et al. Heart rate turbulence after ventricular premature beats as predictor of mortality after acute myocardial infarction. Lancet 1999; 353: 130—196.
31. Kowalewski M. Heart rate turbulence in children — age and heart rate relationships. Pediat Res 2007; 62: 6: 710—714.
32. Комолятова B.H. Характеристика проаритмогенных маркеров электрической нестабильности миокарда у детей и подростков: Автореф. дисс. ... канд. мед. наук. М2009; 22. (KomolyatovaV.N. Featureproarrhythmogenic markers myocardial electrical instability in children and adolescents: Avtoref. dis. ... kand. med. nauk. Moscow 2009; 22.)
33. Brignole M., Auricchio A., Baron-Esquivias G. et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34: 2281-2329.
Рецензия
Для цитирования:
Леонтьева И.В., Макарова В.А., Термосесов С.А. Синкопальные состояния у детей с гипертрофической кардиомиопатией. Российский вестник перинатологии и педиатрии. 2014;59(6):57-65. https://doi.org/10.21508/1027-4065-2014-59-6-35-49
For citation:
Leontyeva I.V., Makarova V.A., Termosesov S.A. Syncope in children with hypertrophic cardiomyopathy. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(6):57-65. (In Russ.) https://doi.org/10.21508/1027-4065-2014-59-6-35-49
Просмотров: 671
Послать статью по эл. почте 